Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M.J. Lorenzo, M. Modesto, M. Muñoz, J. Perez, A. Santa-Cruz, E. Bollo, S. Fernández, R. Cordovilla, M. Lanchas, J.A. Perez-Fidalgo, E. Cases (Valencia, Castellón, Murcia, Spain). Impact of indwelling pleural catheter on quality of life in management of malignant pleural effusion in patients with advanced malignancies. Eur Respir J 2012; 40: Suppl. 56, 3075

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness and safety of tunneled pleural catheter placement in patients with malignant pleural effusions Source: International Congress 2019 – Interventional pulmonology: current pleural practice Year: 2019 The use of the PleurX catheter in the management of recurrent non-malignant pleural effusions Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010 Efficacy and complications of small-bore catheters in the management of malignant pleural effusions Source: Eur Respir J 2007; 30: Suppl. 51, 103s Year: 2007 Utility of indwelling pleural catheters in benign pleural effusions: A single centre experience Source: International Congress 2017 – Pleural interventions and transthoracic ultrasound (TUS) Year: 2017 Malignant pleural effusion management by tunneled pleural catheter Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Malignant pleural disease in primary lung cancer Source: Eur Respir Mon; 2009: 44: 318–335 Year: 2009 Efficacy of doxycycline with small-bore catheters in patients with malignant pleural effusion Source: Eur Respir J 2006; 28: Suppl. 50, 772s Year: 2006 Ultrasonographic predictors of spontaneous pleurodesis in malignant pleural effusion with pleural tunnelled catheters Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside Year: 2017 The use of untunneled indwelling pleural catheters for non-malignant pleural effusions in the outpatient Source: International Congress 2018 – Pleural effusions, infections and tumours Year: 2018 Impact of sarcopenia in long-term symptoms in patients with malignant pleural effusion. Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease Year: 2021 The importance of intrapleurally γ-interferon in ambulatory management of malignant pleural effusion in elderly patients with end-stage NSCCL Source: Eur Respir J 2005; 26: Suppl. 49, 495s Year: 2005 Predictors of survival in patients with recurrent malignant pleural effusion Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases Year: 2008 LATE-BREAKING ABSTRACT: Spontaneous pleurodesis rates in chemotherapy and non-chemotherapy patients undergoing indwelling pleural catheter insertion for malignant pleural effusion Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016 Predictors of successful pleurodesis for patients with malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 493s Year: 2004 Patients with malignant pleural effusions who are treated with indwelling pleural catheters spend fewer days in hospital Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases Year: 2011 Pleurodesis after intrapleural catheter insertion is an independent factor for overall survival in patients with malignant pleural effusions Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours Year: 2009 Indwelling pleural catheters vs. pleurodesis for malignant pleural effusions: a meta-analysis Source: International Congress 2018 – Pleural interventions Year: 2018 Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy Source: Eur Respir J 2003; 22: Suppl. 45, 61s Year: 2003 Use of transthoracic ultrasonography, indwelling pleural catheter and thoracoscopy for the management of malignant pleural effusion Source: International Congress 2019 – PG9 Interventional pulmonology Year: 2019 Optimal management of symptomatic malignant pleural effusions: individualised care Source: Virtual Congress 2021 – Hot news from the pleura Year: 2021